Breethe is a medical device company that develops a compact artificial lung for patients with acute and chronic lung problems. Breethe's system, called the OXY-1 System, is designed to remove carbon dioxide and add oxygen to a patient's blood, much like a working human lung would. The tech eliminates the need for bulky oxygen tanks andallows patients in need of ECMO therapy to move around more easily. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Health Care

Biotechnology

Breethe, Inc.

Dr. Bartley Griffith

Andrew J. Greenfield

Will Danzinger

Todd Tetreault

Thorsten Siess

The Healthcare Management Team at Breethe, Inc. is responsible for overseeing the clinical and regulatory strategies that ensure the safety and efficacy of the OXY-1 System. This team collaborates with healthcare providers to optimize patient outcomes, maintains compliance with medical device regulations, and drives quality assurance initiatives while supporting the development of innovative healthcare solutions for patients with respiratory challenges.

Healthcare Management Team

Leadership Team

Engineering Team

��

Healthcare Management Team

About

Team members

Other teams at Breethe, Inc.

Leadership Team

Engineering Team

��������

Healthcare Management Team

About

Team members

Other teams at Breethe, Inc.

Leadership Team

Engineering Team

��